Target Detachable Coils: TARGET HELICAL NANO 1.5 MM X 4 CM MODEL Number:M0035431540 Neurolog...
FDA Device Recall #Z-2171-2016 — Class II — June 6, 2016
Recall Summary
| Recall Number | Z-2171-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 6, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Stryker Neurovascular |
| Location | Fremont, CA |
| Product Type | Devices |
| Quantity | 45,302 (8,188 in the U.S.) - total, all model numbers |
Product Description
Target Detachable Coils: TARGET HELICAL NANO 1.5 MM X 4 CM MODEL Number:M0035431540 Neurology: Target Detachable Coils are intended to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
Reason for Recall
Stryker Neurovascular has become aware that some units of Target Nano product do not have the intended stretch resistance. The sutures inside the coil that provide stretch resistance may have been damaged during manufacturing which can lead to an increased occurrence of coil stretching.
Distribution Pattern
Worldwide Distribution - US (nationwide) and Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Italia, Japan,Latvia, Lebanon, Libyan Arab Jamahiriya, Lithuania, Luxembourg, Mexico,Netherlands, Norway, Peru, Philippines, Poland, Portugal, Russia, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Uruguay, and Vietnam.
Lot / Code Information
MODEL Number: M0035431540: Lot Number/Expiration Date: 18843121 28-Feb-19 18842254 28-Feb-19 18752256 31-Dec-18 18637622 31-Oct-18 18531974 31-Aug-18 18450202 30-Jun-18 18765704 31-Dec-18 18749439 31-Dec-18 18748627 31-Dec-18 18546175 31-Aug-18 18546117 31-Aug-18 18556378 31-Aug-18 18538344 31-Aug-18 18749033 31-Dec-18 18602307 30-Sep-18 18532032 31-Jul-18 18802864 31-Jan-19 18797083 31-Jan-19 18794216 31-Jan-19 18812672 31-Jan-19 18637738 31-Oct-18 18607230 31-Oct-18 18637680 31-Oct-18 18449404 30-Jun-18 18794100 31-Jan-19 18776421 31-Dec-18 18602365 30-Sep-18 18581643 30-Sep-18 18801549 31-Jan-19 18737036 31-Dec-18 18602249 30-Sep-18 18486380 31-Jul-18 18486322 31-Jul-18 19086644 31-May-19 18941592 31-Mar-19 19086586 31-May-19 18973495 30-Apr-19 19004069 30-Apr-19 18859100 28-Feb-19 18972803 30-Apr-19 19056273 31-May-19 19062764 31-May-19 19003895 30-Apr-19 18973149 30-Apr-19 18956009 31-Mar-19 18893301 28-Feb-19 18894059 28-Feb-19 18860564 28-Feb-19 19003547 30-Apr-19 18955103 31-Mar-19 18942056 31-Mar-19 18886614 28-Feb-19 18894438 28-Feb-19 18941128 31-Mar-19 19083403 31-May-19 18862068 28-Feb-19 18885200 28-Feb-19 19003721 30-Apr-19 19064636 31-May-19.
Other Recalls from Stryker Neurovascular
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0021-2025 | Class II | The Trevo Trak 21 Microcatheter is a single-lum... | Aug 30, 2024 |
| Z-1903-2024 | Class II | Trevo ProVue, Catalog: 90184 | Apr 23, 2024 |
| Z-1908-2024 | Class II | DAC 044 115cm, Catalog: 90760 | Apr 23, 2024 |
| Z-1906-2024 | Class II | Trevo Trak 21 Microcatheter, Catalog: 90338 | Apr 23, 2024 |
| Z-1905-2024 | Class II | Trevo NXT ProVue 3 x 32, US, Catalog: 90312 ... | Apr 23, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.